← Eichor
Condition: Anaplastic Thyroid Carcinomas Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anaplastic Thyroid Carcinomas

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Phase 1 · 2 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06902376Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/Phase 2 · 2 location(s) · University of Arizona · NCT06814496Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
NA · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07068542DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07181720A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · 70 location(s) · Fore Biotherapeutics · NCT05503797Sacituzumab govitEcan in THYroid Cancers
Phase 2 · 11 location(s) · Grupo Espanol de Tumores Neuroendocrinos · NCT06235216Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT03975231Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Phase 2 · 1 location(s) · Saint Petersburg State University, Russia · NCT06374602[177Lu]Lu-AKIR001 First-in-human Study
EARLY_Phase 1 · 1 location(s) · Karolinska University Hospital · NCT06639191NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
Phase 2 · 1 location(s) · Leiden University Medical Center · NCT06079333GETNE Registration of Thyroid Cancer
Phase N/A · 1 location(s) · Grupo Espanol de Tumores Neuroendocrinos · NCT03765333A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06007924
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.